Justin Oldham
Associate Professor - Clinical, Internal Medicine & Pulmonary, Critical Care University of Michigan
Dr. Justin Oldham is a pulmonologist and translational researcher at the University of Michigan, specializing in interstitial lung diseases with a focus on idiopathic pulmonary fibrosis (IPF). His research integrates clinical and genomic data to improve prognostication and identify biomarkers of disease progression and therapeutic response. As Director of the Interstitial Lung Disease Program, he leads efforts to bridge clinical practice with cutting-edge research, advancing personalized approaches to care. Dr. Oldham is widely recognized for his contributions to understanding ILD subtypes and developing data-driven strategies to improve patient outcomes.
Seminars
With new therapies on the horizon, the IPF treatment landscape is evolving. This panel brings together leading clinicians and academics to explore how emerging drugs will fit into current treatment paradigms. Experts will discuss the clinical decision-making process for first-line therapy, balancing efficacy, safety, and patient-specific factors.
- Exploring multi-marker modeling and the potential of combining plasma biomarkers, telomere length, and radiomics to refine patient selection
- Assessing how biomarkers can inform combination therapy strategies and predict treatment response through responder analyses
- Evaluating emerging data on biomarker-driven patient stratification to enhance clinical trial efficiency and success
